Position in NTRA
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$12,215
+$4,016 QoQ
Shares Held
45
+9.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#750
of 844 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JFS WEALTH ADVISORS, LLC holds $571,735 across 20 Diagnostics & Research names. NTRA ranks #11 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
333 | $166,952 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
653 | $126,172 | |
| 3 | RVTY |
Revvity, Inc.
|
424 | $47,174 | |
| 4 | DHR |
Danaher Corp /De/
|
203 | $38,667 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
62 | $32,639 | |
| 6 | DGX |
Quest Diagnostics Inc
|
133 | $28,189 | |
| 7 | WAT |
Waters Corp /De/
|
60 | $22,502 | |
| 8 | A |
Agilent Technologies, Inc.
|
128 | $17,002 |
All Filings in NTRA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,215 | 45 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $8,199 | 41 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $9,392 | 41 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $4,668 | 29 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,237 | 31 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $4,100 | 29 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $3,166 | 20 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,904 | 15 | Shares | Sole | 2024-10-25 | |
| 2021-12-31 | $747 | 8 | Shares | Sole | 2022-02-03 | |
| No filing history on record for this holder in this stock. | ||||||